Merck launches €40m venture fund

The drug conglomerate’s division for pioneering prescription drugs has established Merck Serono Ventures to back emerging biotech companies.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this